Dette medfører forhøjede plasmakoncentrationer af hydrochlorthiazid, som falder langsommere end patienter med normal nyrefunktion.
This results in elevated plasma concentrations of hydrochlorothiazide, which decrease more slowly than in subjects with normal renal function.